MODEL-BASED MABEL APPROACH TO INFORM FIRST-IN-HUMAN DOSE SELECTION OF THE IMMUNO-ONCOLOGY AGONISTIC ANTI-GITR ANTIBODY GWN323.
CLINICAL PHARMACOLOGY & THERAPEUTICS(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2020)